AR042855A1 - Procedimiento mejorado de preparacion de lactamas policiclicas fusionadas con arilos - Google Patents

Procedimiento mejorado de preparacion de lactamas policiclicas fusionadas con arilos

Info

Publication number
AR042855A1
AR042855A1 ARP040100091A ARP040100091A AR042855A1 AR 042855 A1 AR042855 A1 AR 042855A1 AR P040100091 A ARP040100091 A AR P040100091A AR P040100091 A ARP040100091 A AR P040100091A AR 042855 A1 AR042855 A1 AR 042855A1
Authority
AR
Argentina
Prior art keywords
formula
hydrogenation catalyst
fused
alkyl
compound
Prior art date
Application number
ARP040100091A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR042855A1 publication Critical patent/AR042855A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ARP040100091A 2003-01-15 2004-01-14 Procedimiento mejorado de preparacion de lactamas policiclicas fusionadas con arilos AR042855A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44026603P 2003-01-15 2003-01-15

Publications (1)

Publication Number Publication Date
AR042855A1 true AR042855A1 (es) 2005-07-06

Family

ID=32713537

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040100091A AR042855A1 (es) 2003-01-15 2004-01-14 Procedimiento mejorado de preparacion de lactamas policiclicas fusionadas con arilos

Country Status (18)

Country Link
US (1) US20070066827A1 (https=)
EP (1) EP1587794A1 (https=)
JP (1) JP2006517202A (https=)
KR (2) KR20070087258A (https=)
CN (1) CN100363350C (https=)
AR (1) AR042855A1 (https=)
AU (1) AU2004203983A1 (https=)
BR (1) BRPI0406670A (https=)
CA (1) CA2513293A1 (https=)
CL (1) CL2004000041A1 (https=)
IL (1) IL169479A0 (https=)
MX (1) MXPA05007565A (https=)
PL (1) PL379373A1 (https=)
RS (1) RS20050513A (https=)
RU (1) RU2291862C2 (https=)
TW (1) TW200420286A (https=)
WO (1) WO2004063164A1 (https=)
ZA (1) ZA200505103B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100655848B1 (ko) 2002-11-25 2006-12-11 화이자 프로덕츠 인크. 1,3-치환된 인덴의 개선된 제조 방법
RU2372323C1 (ru) * 2008-04-15 2009-11-10 Открытое акционерное общество Научно-производственное предприятие НИИПАВ (ОАО НПП НИИПАВ) Способ получения высокомолекулярных аминов
EP2268639A2 (en) 2008-05-22 2011-01-05 Teva Pharmaceutical Industries Ltd. Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate
WO2009155403A2 (en) * 2008-06-19 2009-12-23 Teva Pharmaceutical Industries Ltd. Processes for the preparation of varenicline and intermediates thereof
EP2438054A1 (en) 2009-06-22 2012-04-11 Teva Pharmaceutical Industries Ltd. Solid states forms of varenicline salts and processes for preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2168791A1 (en) * 1993-08-05 1995-02-16 Arlindo L. Castelhano Matrix metalloprotease inhibitors
DE69839131T3 (de) * 1997-12-31 2015-05-07 Pfizer Products Inc. Arylkondensierte azapolycyclische derivate
US6605610B1 (en) * 1997-12-31 2003-08-12 Pfizer Inc Aryl fused azapolycyclic compounds
AU2002234836B2 (en) * 2001-04-20 2007-08-23 Pfizer Products Inc. Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds

Also Published As

Publication number Publication date
CN100363350C (zh) 2008-01-23
US20070066827A1 (en) 2007-03-22
ZA200505103B (en) 2006-11-29
IL169479A0 (en) 2007-07-04
WO2004063164A1 (en) 2004-07-29
BRPI0406670A (pt) 2005-12-20
RU2291862C2 (ru) 2007-01-20
CN1738803A (zh) 2006-02-22
WO2004063164A8 (en) 2005-05-26
EP1587794A1 (en) 2005-10-26
JP2006517202A (ja) 2006-07-20
CL2004000041A1 (es) 2005-04-22
AU2004203983A1 (en) 2004-07-29
HK1085204A1 (zh) 2006-08-18
PL379373A1 (pl) 2006-08-21
RS20050513A (sr) 2007-11-15
CA2513293A1 (en) 2004-07-29
MXPA05007565A (es) 2005-09-21
TW200420286A (en) 2004-10-16
RU2005122406A (ru) 2006-01-27
KR20070087258A (ko) 2007-08-27
KR20050101177A (ko) 2005-10-20

Similar Documents

Publication Publication Date Title
ES2634087T3 (es) Lípidos biodegradables para la administración de agentes activos
AR082747A1 (es) Procesos para la preparacion de inhibidores jak, los compuestos intermediarios y composiciones farmaceuticas que los contienen
AR039150A1 (es) Piridinoilpiperidinas como agonistas de 5-ht1f
AR046272A1 (es) Inhibidores de dipeptidil peptidasa iv
UY27039A1 (es) Formas de sal de amida de acido 3-(4-bromo-2,6-difluoro-benciloxi)-5-(3-(pirrolidin-1-ilbutil)ureido)isotiazol-4-carboxilico y métodos de producción
EA201591078A1 (ru) Пептиды в качестве агонистов окситоцина
RU2008111991A (ru) Органические соединения
DOP2006000125A (es) Derivados de ciclohexanosulfonilo como inhibidores de glyt1 para tratar esquizofrenia
AR074863A1 (es) Proceso y compuestos intermedios para preparar un inhibidor de proteasa macrociclico del vhc
WO2023077127A2 (en) N-substituted indoles
AR048973A1 (es) (4-metoxi-7-morfolin-4-il-benzotiazol-2-il)amida del acido 4-hidroxi-4-metil-piperidin-1-carboxilico. proceso de preparacion y composiciones farmaceuticas
AR042855A1 (es) Procedimiento mejorado de preparacion de lactamas policiclicas fusionadas con arilos
ECSP11011196A (es) Derivados de piperidina
AR054102A1 (es) Derivados de fenil-piperazina-metanona. procesos de obtencion y composiciones farmaceuticas
FR2799757A1 (fr) Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2007125660A (ru) Фенилпиперазиновые производные с сочетанием свойств неполного агонизма к рецепторам дофамина-d2 и ингибирования повторного поглощения серотонина
AR036351A1 (es) Isoxazolopiridinonas, el uso de las mismas para la fabricacion de un medicamento, composiciones y combinaciones farmaceuticas
AR066722A1 (es) Compuestos de hidroxietilamina sustituida como moduladores de la beta-secretasa y metodos de uso
AR036166A1 (es) Compuestos de octahidro-2h-pirido[1,2-a]piracina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen
DE69407751T2 (de) Phenylethyl-und phenylpropylamine
ES2307974T3 (es) Procedimiento de preparacion de acido indan-1,2-dicarboxilico.
AR081382A1 (es) Derivados de n-heterocicloalquil bipirrolidinilfenil amida sustituidos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades del sistema nervioso central.
ES2982231T3 (es) Estereotetradas escalables de polipropionato lactona
AR046733A1 (es) Procedimiento para preparar derivados de (3- oxo-2,3- dihidro - 1h- isoindol-1-il) -acetilguanidina
RU2009108734A (ru) Способ получения производных n-метиладамантила посредством катализируемой палладием реакции сочетания с последующим восстановительным аминированием

Legal Events

Date Code Title Description
FC Refusal